UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
|
|
|
OMB Number:
|
|
3235-0060 |
Expires:
|
|
April 30, 2009 |
Estimated average burden
hours per response.................28.0 |
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 1, 2008
BFC FINANCIAL CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Florida
|
|
001-09071
|
|
59-2022148 |
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.) |
|
|
|
2100 West Cypress Creek Road, Fort Lauderdale, Florida
|
|
33309 |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code) |
Registrants telephone number, including area code: (954) 940-4900
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
|
|
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
|
|
|
Item 3.01 |
|
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;
Transfer of Listing. |
As previously disclosed, on May 20, 2008, BFC Financial Corporation (the Company) was
notified by NYSE Arca, Inc. (the NYSE Arca) that the Company did not have a market value of
publicly held shares in excess of $15 million or an average closing price per share of its Class A
Common Stock in excess of $1.00 for a consecutive 30 trading-day period, as required for continued
listing. Pursuant to the rules and regulations of the NYSE Arca, the Company was granted a
six-month cure period to regain compliance with these continued listing requirements. Because
compliance was not achieved within this six-month cure period, on December 1, 2008, the Company was
notified by the NYSE Arca that its Class A Common Stock will be suspended from trading on the NYSE
Arca prior to the opening of the market on Tuesday, December 9, 2008. The Company anticipates
that its Class A Common Stock will be quoted on the OTCs
Pink Sheet Electronic Quotation Service as soon as the NYSE Arca suspends trading.
2